摘要
目的 探讨血浆α2巨球蛋白(α2-MG)水平与小动脉闭塞型(SAO)脑梗死发病及认知功能的关系.方法 在青岛大学附属医院神经内科自2012年12月至2013年9月收治的患者中选取符合TOAST分型中SAO型脑梗死患者58例(SAO组)、大动脉粥样硬化型(LAA)脑梗死患者56例(LAA组)以及同期体检健康的正常者53例(健康对照组),应用酶联免疫吸附测定法(ELISA)检测血浆α2-MG水平并比较组间差异,绘制受试者工作特征曲线(ROC)判断血浆α2-MG水平对SAO型脑梗死的诊断价值.同时对SAO组进行简易精神状态量表(MMSE)测评,并对其颅脑MRI进行Fazekas评分评判脑白质损害(WMLs)程度,比较不同WMLs程度患者血浆α2-MG水平差异,分析血浆α2-MG水平与MMSE量表评分及Fazekas评分的相关性.结果 与LAA组[(5.04±1.93) μg/mL]、健康对照组[(4.86±1.68) μg/mL]相比,SAO组血浆α2-MG水平[(6.70±3.17)μg/mL]明显增高,差异均有统计学意义(P<0.05);二元Logistic回归分析显示血浆α2-MG水平是SAO型脑梗死的独立危险因素(OR=1.409,P=0.001;OR=1.443,P=0.004).ROC曲线显示4.23μg/mL α2-MG水平为诊断SAO型脑梗死的最佳临界值,灵敏度可达86.2%.不同WMLs程度的SAO型脑梗死患者间血浆α2-MG水平差异有统计学意义(F=26.509,P=0.000),且血浆α2-MG水平与Fazekas评分呈正相关(r=0.733,P=0.000),与MMSE量表评分呈负相关(r=-0.679,P=0.000).结论 α2-MG可作为诊断SAO型脑梗死的血浆标志物,是其独立危险因素,且其水平与认知功能障碍程度及WMLs程度密切相关.
Objective To investigate the relationships of plasma alpha2-macroglobulin (α2-MG) level with occurrence of small-artery occlusion (SAO) and cognitive function in SAO patients.Methods Subjects were collected in our hospital from December 2012 to September 2013;58 patients with SAO stroke,56 with large artery atherosclerosis (LAA) classified by Trial of Org 10172 in Acute Stroke Treatment (TOAST),as well as 58 healthy controls,were enrolled.The serum α2-MG levels were measured by enzyme-linked immunosorbent assay (ELISA) and compared among the three groups.The receiver operating characteristic (ROC) curve was drawn to evaluate the value of α2-MG as a biomarker for SAO.White matter lesions (WMLs) were assessed by MRI using Fazekas classification,and mini-mental state examination (MMSE) was used to evaluate the cognitive function.The correlations of plasma α2-MG level with both Fazekas scores and MMSE scores were analyzed.Results The serum α2-MG levels in SAO patients ([6.70±3.17] μg/mL) were significantly higher than those in LAA patients ([5.04±1.93] μg/mL) and controls ([4.86±1.68] μg/mL) (P〈0.05).Binary Logistic regression analysis showed that the plasma α2-MG level was an independent risk factor for occurrence of SAO (OR=1.409,P=0.001;OR=1.443,P=0.004).The ROC curves obtained that α2-MG=4.23 μg/mL was the cutoff values for SAO,enjoying sensitivity up to 86.2%.SAO patients with different severities of WMLs had significantly different serum α2-MG levels (F=26.509,P=0.000);the serum α2-MG levels were positively correlated with Fazekas scores (r=0.733,P=0.000) and negatively correlated with MMSE scores (r=-0.679,P=0.000).Conclusions Serum α2-MG level is an independent risk factor for SAO and might be a biomarker for SAO.Furthermore,serum α2-MG level,being associated with high-grade WMLs,might contribute to evaluating the cognitive impairment in SAO patients.
出处
《中华神经医学杂志》
CAS
CSCD
北大核心
2015年第5期483-486,共4页
Chinese Journal of Neuromedicine
基金
山东省自然科学基金(ZR2013HM022)